Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors. Heynen GJJE, Lisek K, Vogel R, Wulf-Goldenberg A, et al. Breast Cancer Res 2022;24:23.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heynen GJJE, Lisek K, Vogel R, Wulf-Goldenberg A, et al. Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors. Breast Cancer Res 2022;24:23.
PMID: 35365185